‼️ Mobile apps are powerful tools to monitor symptoms and engage in treatment for patients with liver disease

✅ Our editorial with Elliot Tapper summarizes the mobile apps in liver disease and offers suggestions for the path forward Hepatology Communications

journals.lww.com/hepcomm/fullte…

1/⏰ for #EBGI Tweetorial🧵w/ Fnu Vikash, MD & Peter Bhandari, MD

“Add Pancreatic Duct Stent to Indomethacin to Minimize Post-ERCP Pancreatitis in High-Risk Patients”

📜 Summary: shorturl.at/BCEI9
🎧 shorturl.at/ilp09
📰 shorturl.at/HJSXY The Lancet

🔍Check out our new study on the recipient outcomes of DDLT vs LDLT for ALF in the US!

🔗 mdpi.com/2077-0383/13/6…

📣Today marks the start of #ColorectalCancerAwarenessMonth !

Join us as we talk about prevention, screening and raising awareness w/ our #EBGIxCRC campaign with various events👇

Register here for the ACG VGR special on 3/26 bit.ly/49CWjYS 🎙️🌟

1/ ⏰ for #EBGI 🧵w/ Kuntal Bhowmick, MD!

“Non-Erosive GERD Does Not Lead to an Increased Risk of Esophageal Adenocarcinoma: A Nordic Population Based Cohort Study”

📜 - shorturl.at/pJP56
🎧 - shorturl.at/htzA2
📰 - shorturl.at/hrtuZ

#GITwitter

1/ It's #EBGITweetorial 🧵w/ Kashyap Chauhan, MD !

‘’HCC incidence rates are 2%-3% in US patients with cirrhosis regardless of etiology’’

📜Summary:shorturl.at/beOQX
🎧 : shorturl.at/jpuIP
📰 in @AGA_Gastrojournal. Current🔗: shorturl.at/jsI16

Excited to be presenting our studies at #DDW2024 in DC and reunite with the Evidence-Based GI: An ACG Publication (EBGI) team! ✈️

Digestive Disease Week AASLD

Our new paper on AKI & HRS-AKI in cirrhosis is out!

✅ Approach to AKI in cirrhosis
✅ Diagnosis and management of HRS-AKI
❓Differing ATN vs HRS-AKI
❓Utility of biomarkers

mdpi.com/2077-0383/13/1…

Great case on turmeric liver injury by Alsadiq Al-Hillan at the Michigan Hepatotoxicity GI Forum #DILIN by Dr. Robert Fontana and Michigan Hepatology

#GITwitter #LiverTwitter #AASLD

CH-BeaumontRO-GIHepfellow crew
Ihab Kassab, MD Samiksha Pandey, MD, MSc Begüm Öztürk, MD

Excited to attend my first ASCO #GI24 at San Francisco and present our research on iCCA!

Wondering the efficacy of Thalidomide for small intestinal angiodysplasia? ⁉️

Follow this thread by Sean-Patrick Prince, MD, MPH for answers ⏬

#mdpijcm
🔥 Altmetric High-scoring paper: 'A Comprehensive Review of the Diagnosis and Management of Acute Liver Failure' by Begüm Öztürk, MD et al.
👉Read more: mdpi.com/2584224

#liver #hepatitis #transplantation #IntensiveCare

Happy to share the new ACG 'Clinical Guideline: Alcohol-Associated Liver Disease':

🔸Increasing in young women
🔸Early detection needed
🔸Criteria for early LT for AH

ACG bit.ly/AJG-EtOH-Guide… #livertwitter #MedTwitter

Super excited to share my case report with Begüm Öztürk, MD on Acute renal injury in IgG-4 related disease
tandfonline.com/eprint/FAT2ERP…

1/⏰ for #EBGI Tweetorial🧵w/ Begüm Öztürk, MD & Mohamad I. Itani, MD!

“Surveillance of Branch Duct IPMN–Enough is Enough, At Least in Older Adults and Small, Stable Lesions”

📜Summary bit.ly/IPMN1 Shria Kumar
🎧 bit.ly/IPMNpod
📰 in Gastroenterology bit.ly/IPMNfull

Check out our new 📝 on ischemic colitis with pneumatosis intestinalis and portomesenteric venous gas on imaging!

ACG ACGCRJ Ayca Kutlu, MD

journals.lww.com/acgcr/fulltext…

Check out our new paper on #ALF 📝

We review the current evidence and practice for acute liver failure and discuss:

✅ Medical management and ICU care
❓ When to consider transplant

pubmed.ncbi.nlm.nih.gov/38068503/

The wait is over😍

Evidence-Based GI: An ACG Publication (EBGI) is now accepting up to 8 new ambassadors (both residents and fellows)🥳

Do you want to learn #SoME skills, share high-quality summaries & engage w/ #GITwitter ? We're the family to join😀

Submission deadline Dec 30.
🔗rb.gy/35am0i

And one final updated pic at #TLM2023 AASLD

Just a couple of friends showing up for Mayo Clinic Gastroenterology & Hepatology talks on experimental #MASH . Incredible support and friendship 🫶

#TLM23 AASLD